5-[3-[(2R)-2-[(E,3S)-3-hydroxy-4-phenylbut-1-enyl]-6-oxopiperidin-1-yl]propyl]-1,3-oxazole-2-carboxylic acid

C22H26N2O5 — CID 67319911

IUPAC5-[3-[(2R)-2-[(E,3S)-3-hydroxy-4-phenylbut-1-enyl]-6-oxopiperidin-1-yl]propyl]-1,3-oxazole-2-carboxylic acid
SMILESO=C(O)c1ncc(CCCN2C(=O)CCC[C@@H]2/C=C/[C@@H](O)Cc2ccccc2)o1
InChIInChI=1S/C22H26N2O5/c25-18(14-16-6-2-1-3-7-16)12-11-17-8-4-10-20(26)24(17)13-5-9-19-15-23-21(29-19)22(27)28/h1-3,6-7,11-12,15,17-18,25H,4-5,8-10,13-14H2,(H,27,28)/b12-11+/t17-,18-/m1/s1
InChIKeyRPZQEAPGYQQSPI-LLSOJIOMSA-N
MW398.46 g/mol
LogP2.85
Rot. Bonds9

About 5-[3-[(2R)-2-[(E,3S)-3-hydroxy-4-phenylbut-1-enyl]-6-oxopiperidin-1-yl]propyl]-1,3-oxazole-2-carboxylic acid

5-[3-[(2R)-2-[(E,3S)-3-hydroxy-4-phenylbut-1-enyl]-6-oxopiperidin-1-yl]propyl]-1,3-oxazole-2-carboxylic acid (PubChem CID 67319911) has the molecular formula C22H26N2O5 and a molecular weight of 398.46 g/mol. Its IUPAC name is 5-[3-[(2R)-2-[(E,3S)-3-hydroxy-4-phenylbut-1-enyl]-6-oxopiperidin-1-yl]propyl]-1,3-oxazole-2-carboxylic acid.

Molecular Properties

Compound Name5-[3-[(2R)-2-[(E,3S)-3-hydroxy-4-phenylbut-1-enyl]-6-oxopiperidin-1-yl]propyl]-1,3-oxazole-2-carboxylic acid
PubChem CID67319911
Molecular FormulaC22H26N2O5
Molecular Weight398.46 g/mol
Exact Mass398.18
IUPAC Name5-[3-[(2R)-2-[(E,3S)-3-hydroxy-4-phenylbut-1-enyl]-6-oxopiperidin-1-yl]propyl]-1,3-oxazole-2-carboxylic acid
SMILESO=C(O)c1ncc(CCCN2C(=O)CCC[C@@H]2/C=C/[C@@H](O)Cc2ccccc2)o1
InChIInChI=1S/C22H26N2O5/c25-18(14-16-6-2-1-3-7-16)12-11-17-8-4-10-20(26)24(17)13-5-9-19-15-23-21(29-19)22(27)28/h1-3,6-7,11-12,15,17-18,25H,4-5,8-10,13-14H2,(H,27,28)/b12-11+/t17-,18-/m1/s1
InChIKeyRPZQEAPGYQQSPI-LLSOJIOMSA-N
XLogP2.85
TPSA103.87 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds9
Heavy Atoms29
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500398.46
LogP ≤ 52.85
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze 5-[3-[(2R)-2-[(E,3S)-3-hydroxy-4-phenylbut-1-enyl]-6-oxopiperidin-1-yl]propyl]-1,3-oxazole-2-carboxylic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 5-[3-[(2R)-2-[(E,3S)-3-hydroxy-4-phenylbut-1-enyl]-6-oxopiperidin-1-yl]propyl]-1,3-oxazole-2-carboxylic acid?
The IUPAC name of 5-[3-[(2R)-2-[(E,3S)-3-hydroxy-4-phenylbut-1-enyl]-6-oxopiperidin-1-yl]propyl]-1,3-oxazole-2-carboxylic acid (CID 67319911) is 5-[3-[(2R)-2-[(E,3S)-3-hydroxy-4-phenylbut-1-enyl]-6-oxopiperidin-1-yl]propyl]-1,3-oxazole-2-carboxylic acid.
What is the SMILES notation for 5-[3-[(2R)-2-[(E,3S)-3-hydroxy-4-phenylbut-1-enyl]-6-oxopiperidin-1-yl]propyl]-1,3-oxazole-2-carboxylic acid?
The canonical SMILES for 5-[3-[(2R)-2-[(E,3S)-3-hydroxy-4-phenylbut-1-enyl]-6-oxopiperidin-1-yl]propyl]-1,3-oxazole-2-carboxylic acid is O=C(O)c1ncc(CCCN2C(=O)CCC[C@@H]2/C=C/[C@@H](O)Cc2ccccc2)o1.
What is the InChIKey of 5-[3-[(2R)-2-[(E,3S)-3-hydroxy-4-phenylbut-1-enyl]-6-oxopiperidin-1-yl]propyl]-1,3-oxazole-2-carboxylic acid?
The InChIKey is RPZQEAPGYQQSPI-LLSOJIOMSA-N. The full InChI is InChI=1S/C22H26N2O5/c25-18(14-16-6-2-1-3-7-16)12-11-17-8-4-10-20(26)24(17)13-5-9-19-15-23-21(29-19)22(27)28/h1-3,6-7,11-12,15,17-18,25H,4-5,8-10,13-14H2,(H,27,28)/b12-11+/t17-,18-/m1/s1.
What are the key properties of 5-[3-[(2R)-2-[(E,3S)-3-hydroxy-4-phenylbut-1-enyl]-6-oxopiperidin-1-yl]propyl]-1,3-oxazole-2-carboxylic acid?
5-[3-[(2R)-2-[(E,3S)-3-hydroxy-4-phenylbut-1-enyl]-6-oxopiperidin-1-yl]propyl]-1,3-oxazole-2-carboxylic acid has a molecular weight of 398.46 g/mol, XLogP of 2.85, 9 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[3-[(2R)-2-[(E,3S)-3-hydroxy-4-phenylbut-1-enyl]-6-oxopiperidin-1-yl]propyl]-1,3-oxazole-2-carboxylic acid is sourced from PubChem (CID 67319911), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).